Insider Selling: Electromed, Inc. (NYSE:ELMD) Director Sells $278,640.00 in Stock

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 8,640 shares of the company’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $32.25, for a total value of $278,640.00. Following the completion of the sale, the director now owns 71,576 shares in the company, valued at approximately $2,308,326. This represents a 10.77 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Kathleen Skarvan also recently made the following trade(s):

• On Tuesday, February 18th, Kathleen Skarvan sold 38,954 shares of Electromed stock. The shares were sold at an average price of $29.28, for a total value of $1,140,573.12.

Electromed Price Performance

NYSE:ELMD opened at $27.97 on Friday. The business’s 50-day moving average is $31.40 and its two-hundred day moving average is $25.26. Electromed, Inc. has a 12 month low of $13.74 and a 12 month high of $35.56. The firm has a market capitalization of $239.42 million, a PE ratio of 37.29 and a beta of 0.33.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ELMD. StockNews.com lowered Electromed from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. B. Riley began coverage on Electromed in a research note on Thursday. They set a “buy” rating and a $38.00 price target on the stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Arrowstreet Capital Limited Partnership raised its position in Electromed by 261.0% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 114,579 shares of the company’s stock valued at $3,386,000 after purchasing an additional 82,839 shares during the period. Hunter Associates Investment Management LLC raised its position in Electromed by 12.3% in the third quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock valued at $2,199,000 after purchasing an additional 11,250 shares during the period. Northern Trust Corp increased its position in shares of Electromed by 14.1% during the fourth quarter. Northern Trust Corp now owns 65,350 shares of the company’s stock worth $1,931,000 after acquiring an additional 8,086 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Electromed in the fourth quarter worth about $1,760,000. Finally, Susquehanna International Group LLP boosted its holdings in Electromed by 121.8% in the fourth quarter. Susquehanna International Group LLP now owns 56,726 shares of the company’s stock valued at $1,676,000 after purchasing an additional 31,148 shares during the last quarter. 40.82% of the stock is owned by hedge funds and other institutional investors.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.